Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTACarolin Dorothea Strobl, Michael Aigner|Molecular Cancer Therapeutics|2019Cited by 35